Health and Global Policy Institute (HGPI) collaborated as the Japanese secretariat of the Partnership for Health System Sustainability and Resilience (PHSSR) at the PHSSR Summit 2025, held on 30 June 2025 at the Osaka, Kansai Expo, with the theme ‘Co-creating Stronger Health Systems -Transformative Care for All.’ Moreover, Mr. Ryoji Noritake, Chair of HGPI, moderated the session titled ‘Part 1: Early Action on NCDs.’

The COVID-19 pandemic exposed the frailties of health systems worldwide, highlighting the urgent need to develop healthcare systems that are sustainable, durable and resilient. In response to this global challenge, the Partnership for Health System Sustainability and Resilience (PHSSR) was launched in 2020 by the World Economic Forum (WEF) and the London School of Economics and Political Science (LSE), in collaboration with global partners. PHSSR conducts its activities through analyses based on seven core domains—governance, financing, healthcare workforce, service delivery, medical products and technologies, population health, and environment. These domains serve as a framework to identify the strengths, weaknesses, opportunities, and challenges of health systems in different countries, and for developing actionable, evidence-based recommendations.

PHSSR has entered a new phase with the full-scale launch of its “Policy Roadmaps”. The initial focus of this phase is on “acting early on non-communicable diseases (NCDs),” with the aim of presenting evidence-based, actionable policy recommendations and measurable national targets tailored for implementation across participating countries.
This phase places a strategic focus on early action (“Acting Early”) to counter leading causes of death globally, such as cancer, cardiovascular diseases, diabetes, chronic respiratory conditions, and kidney disease. It aims to offer actionable, measurable policy recommendations that can be implemented across countries.

This Summit provided a valuable opportunity to advance discussions on two key global health priorities, namely early intervention for non-communicable diseases (NCDs) and the promotion of healthcare digital transformation (DX). These priorities are also central to Japan’s efforts to redesign its health system in response to a super-aging society. Policymakers, experts, and stakeholders from Japan and around the world came together to explore the future of healthcare systems through diverse perspectives. The event also served as a platform to present critical interim outcomes from the new phase of the PHSSR “Policy Roadmaps” initiative.

[Event Overview]

• Date & Time: Monday, June 30,2025 14:00-19:05 JST
• Format: Hybrid
• Venue: EXPO 2025 Osaka, Kansai – Theme Week Studio
• Language: Japanese and English (simultaneous interpretation provided)
• Organizer: EXPO 2025 Thematic Project “Resonance of Lives” (Producer: Hiroaki Miyata)
• Co-organizer: AstraZeneca K.K.
• In collaboration with: Health and Global Policy Institute (HGPI) / PHILIPS / IQVIA / Roche Diagnostics
• Supported by: British Embassy Tokyo / British Consulate-General / Embassy of the Netherland / Embassy of Sweden / Ministry of Health, Labour and Welfare

[Program] (Title omitted, in no particular order, affiliation and title at the time of participation)

14:00-14:25	Opening Remarks
	Michel Demaré (Non-Executive Chair of the Board, AstraZeneca PLC)
	Keizo Takemi (House of Councillors, Japan / Former Minister, Health, Labour adnWelfare) *video
	Elias Mossialos (Cheng Yu Tung Chair in Global Health, LSE Health Director, Department of Health Policy, The London School of Economics and `Political Science)
	Hiroaki Miyata (Professor, Health Policy and Management, Keio University School of Medicine)
Session 1 Early Action on NCDs
14:25-14:35	Introduction
	Elias Mossialos (Cheng Yu Tung Chair in Global Health, LSE Health Director, Department of Health Policy, The London School of Economics and `Political Science)
14:35-15:30	Panel 1: PHSSR Policy Road Map Japan
	Presentation  Shuhei Nomura (Specially Appointed Professor, Global Research Institute. Keio University) Panel Discussion Moderator:  Ryoji Noritake (Chair, Health and Global Policy Institute) Panelists: Shigekazu Komoto (Professor, School of medicine, Hokkaido University / Former Director, Cancer and Disease Control Division, Ministry of Health, Labour and Welfare) Yasuhiro Suzuki (President, International University of Health and Welfare / Former Vice-Minister for Health, Ministry of Health, Labour and Welfare) Shuhei Nomura (Specially Appointed Professor, Global Research Institute. Keio University) Reiko Hayashi (Director-General, National Institute of Population and Social Security Research (IPSS))
15:30-15:45	Global Case Studies
	Elias Mossialos (Cheng Yu Tung Chair in Global Health, LSE Health Director, Department of Health Policy, The London School of Economics and `Political Science) Chris Licskai (Schulich School of Medicine & Dentistry, Western University) *Video Heinrich Worth (Pneumological and Cardiological Practice) *video  Stephen Holt (Director and CEO, SEHA Kidney Care) *video
15:45-16:30	Panel 2: Learnings and Opportunities from Global Best Practices
	Moderator:  Ryoji Noritake (Chair, Health and Global Policy Institute) Panelists:  Hiromi Todoroki (Board member, The Japan Federation of Cancer Patient Groups / Chair, Certified non-profit organization ‘KIBOUNOKAI’) Jun Sasaki (Chief Executive Officer and Director at Yushoukai Medical Corporation / Expert Member, the Council for Promotion of Regulatory Reform) Shoichiro Tsugane (Professor, Graduate School of Public Health, International University of Health and Welfare / Former Director of the Centre for Public Health Sciences, National Cancer Center) Koichi Fukunaga (Professor, Pulmonary Division, Department of Medicine, Keio University, School of Medicine)
16:30-16:45	Intermission
Section 2  How to accelerate Healthcare DX
16:45-17:15	Panel 1: mproving Healthcare delivery systems through digitization from a country perspective
	Moderator: Elias Mossialos (Cheng Yu Tung Chair in Global Health, LSE Health Director, Department of Health Policy, The London School of Economics and `Political Science) Panelists: Chang-Chuan Chan (Distinguished Professor, Global Health Program, Collage of Public Health, National Taiwan University / Member of the board, CAPRI) Jan-Willem Scheijgrond (Vice President, Global Government & Public Affairs, Royal Philips) Fumihiko Ugajin (President, IQVIA JAPAN) Hiroyuki Komatsu (Head of Business Innovation. Roche Diagnostics Japan)
17:15-18:05	Panel 2: The use and challenges of Healthcare DX in Japan
	Moderator:  Mamoru Ichikawa (A Healthcare Communicator / Associate Professor, Department of Media Sociology, Faculty of Sociology, Musashi University / Executive Board Member, Japan Medical Journalists Association) Panelists:  Hiroyuki Uchiyama (Assistant Vice-Minister for Pharmaceutical Industry Promotion and Medical Information Management, MHLW) Yusuke Tsugawa (Associate Professor, Medicine and Health Policy and Management at UCLA / Medical Doctor） Makiko Nakamuro (Professor, Faculty of Policy Management, Keio University) Hitoshi Fukuhara (Representative Director, Heart Valve Voice) Takafumi Horii (President and Representaive Director. AstraZeneca K.K.)
17:15-18:20	Closing Remarks
	Masaaki Taira (Minister)*video
	The Rt. Hon the Lord Lansley CBD (Member of the House of Lords, United Kingdom) *video
	Emil Levendoǧlu (Minister and Deputy Head Mission to Japan, British Embassy in Tokyo)
18:20-19:05	Networking